NCT03537235View on ClinicalTrials.gov

Evaluation of Libramed in Obesity Treatment

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 29, 2015

Primary Completion Date

February 22, 2019

Study Completion Date

February 22, 2019

Conditions
Overweight and Obesity
Interventions
DEVICE

Libramed

DEVICE

Placebo

Trial Locations (1)

40-767

"Metabolic Management Center LINIA", Katowice

All Listed Sponsors
collaborator

Sprim Advanced Life Sciences

OTHER

lead

Aboca Spa Societa' Agricola

INDUSTRY

NCT03537235 - Evaluation of Libramed in Obesity Treatment | Biotech Hunter | Biotech Hunter